| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,540,000 |
| Market
Cap: |
346.61(M) |
| Last
Volume: |
34,905,322 |
Avg
Vol: |
12,426,713 |
| 52
Week Range: |
$4.1 - $4.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-10-15 |
4 |
OE |
$5.33 |
$79,950 |
D/D |
15,000 |
710,148 |
|
- |
|
| Scheinberg David A |
Director |
– • – |
2007-10-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,501 |
38,682 |
|
- |
|
| Scheinberg David A |
Director |
– • – |
2007-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,504 |
38,685 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$16,255 |
D/D |
(726) |
35,730 |
|
- |
|
| Israel Robert J |
Sr. VP, Medical Affairs |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$15,186 |
D/D |
798 |
36,456 |
|
- |
|
| Kremer Alton B |
VP, Clinical Research |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$47,444 |
D/D |
(2,119) |
29,685 |
|
- |
|
| Kremer Alton B |
VP, Clinical Research |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$44,302 |
D/D |
2,328 |
31,804 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-10-01 |
4 |
D |
$22.39 |
$40,660 |
D/D |
(1,816) |
695,148 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-10-01 |
4 |
OE |
$5.33 |
$101,925 |
D/D |
13,995 |
696,964 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-10-01 |
4 |
AS |
$22.03 |
$264,312 |
D/D |
(12,000) |
694,969 |
|
- |
|
| Olson William C |
VP, Research & Development |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$9,493 |
D/D |
(424) |
32,756 |
|
- |
|
| Olson William C |
VP, Research & Development |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$8,868 |
D/D |
466 |
33,180 |
|
- |
|
| Mckinney Robert A |
Chief Financial Officer |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$11,508 |
D/D |
(514) |
33,448 |
|
- |
|
| Mckinney Robert A |
Chief Financial Officer |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$10,752 |
D/D |
565 |
33,962 |
|
- |
|
| Boyd Thomas A |
Sr. VP, Product Dev. |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$41,354 |
D/D |
(1,847) |
36,441 |
|
- |
|
| Boyd Thomas A |
Sr. VP, Product Dev. |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$38,612 |
D/D |
2,029 |
38,288 |
|
- |
|
| Baker Mark Robert |
General Counsel |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$15,248 |
D/D |
(681) |
24,877 |
|
- |
|
| Baker Mark Robert |
General Counsel |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$14,234 |
D/D |
748 |
25,558 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-09-17 |
4 |
AS |
$23.39 |
$280,728 |
D/D |
(12,000) |
694,969 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-09-17 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
706,969 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-09-04 |
4 |
AS |
$23.77 |
$285,180 |
D/D |
(12,000) |
694,969 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-09-04 |
4 |
OE |
$5.33 |
$63,960 |
D/D |
12,000 |
706,969 |
|
- |
|
| Boyd Thomas A |
Sr. VP, Product Dev. |
• – – |
2007-08-15 |
4 |
AS |
$22.85 |
$45,799 |
D/D |
(2,000) |
36,209 |
|
- |
|
| Boyd Thomas A |
Sr. VP, Product Dev. |
• – – |
2007-08-15 |
4 |
OE |
$13.63 |
$32,598 |
D/D |
2,000 |
36,709 |
|
- |
|
| Maddon Paul J |
Chief Executive Officer/CSO |
• – • |
2007-08-15 |
4 |
AS |
$23.16 |
$277,860 |
D/D |
(12,000) |
694,969 |
|
- |
|
801 Records found
|
|
Page 14 of 33 |
|
|
